دورية أكاديمية

The Challenge of Diagnosis and Indication for Treatment in Fabry Disease

التفاصيل البيبلوغرافية
العنوان: The Challenge of Diagnosis and Indication for Treatment in Fabry Disease
المؤلفون: Marco A. Curiati MD, Carolina S. Aranda MD, MSc, Sandra O. Kyosen MD, MSc, Patricia Varela MSc, Vanessa G. Pereira PhD, Vania D’Almeida PhD, João B. Pesquero PhD, Ana M. Martins MD, PhD
المصدر: Journal of Inborn Errors of Metabolism and Screening, Vol 5 (2017)
بيانات النشر: SciELO, 2017.
سنة النشر: 2017
المجموعة: LCC:Medicine (General)
مصطلحات موضوعية: Medicine (General), R5-920
الوصف: Fabry disease, caused by deficient alpha-galactosidase A lysosomal enzyme activity, remains challenging to health-care professionals. Laboratory diagnosis in males is carried out by determination of alpha-galactosidase A activity; for females, enzymatic activity determination fails to detect the disease in about two-thirds of the patients, and only the identification of a pathogenic mutation in the GLA gene allows for a definite diagnosis. The hurdle to be overcome in this field is to determine whether a mutation that has never been described determines a “classic” or “nonclassic” phenotype, because this will have an impact on the decision-making for treatment initiation. Besides the enzymatic determination and GLA gene mutation determination, researchers are still searching for a good biomarker, and it seems that plasma lyso-Gb3 is a useful tool that correlates to the degree of substrate storage in organs. The ideal time for treatment initiation for children and nonclassic phenotype remains unclear.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2326-4594
23264098
العلاقة: https://doaj.org/toc/2326-4594Test
DOI: 10.1177/2326409816685735
الوصول الحر: https://doaj.org/article/7fb1bf189e654956948a707ace4f87c7Test
رقم الانضمام: edsdoj.7fb1bf189e654956948a707ace4f87c7
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:23264594
23264098
DOI:10.1177/2326409816685735